
An exploration into modern-day concerns on genetic screening
This article is from the equity heathcare and bio quest partnership
As expected, this raised objection from scientists globally, most notably the PGC (Psychiatric Genomic Consortium, whose data was used to determine Orchid Health’s risk estimates) as their “goal is to improve the lives of people with mental illness, not stop them from being born”. Concerns arise when speaking of the future use of polygenic risk scores in genetic screening. With increasingly more accurate technology and data analysis, will society be able to accurately predict characteristics (not just diseases) of each embryo? Some also argue that the financial implications of this treatment may further increase the inequality divide whilst also putting a cost on the difference between a healthy life and life of a sufferer of a genetic disorder (e.g., polydactyly). This implies the suffering of people with genetic disorders is quantifiable to a grand sum of £2500, thus further raising ethical issues as that clearly disregards the physical and psychological impact a genetic disorder can have on the sufferer and the people around them. Proponents of this research (like geneticist Mark Daly) argue that the point of genetic research should be to understand the ‘mechanisms of disease’, allowing for the discovery of new treatments to combat genetic disorders. A study in the Delaware Journal of Public Health supports this view of genetic screening, citing how understanding of the pathway of Pelizaeus Merzbacher disease helped create 'novel gene therapies’ to stop the spinal muscular atrophy associated with this genetic disease.
To conclude, it is clear to see that genetic screening is a tool that can be used to effectively treat many genetic disorders and improve the lives of countless sufferers. However, in the words of Andrew McQuillin (a researcher at PGC), ‘Society must soon have a broader discussion about the implications of this type of genetic screening’, due to the worrying ethical dilemmas that arise from paying for whole genome sequencing.
Keywords:
Mutations: A change in the gene in the genetic sequence Homozygous: Having two identical alleles of the same gene Phenotype: The set of observable characteristics resulting from a specific genotype
Eugenics: a study on how to pass down desired characteristics within a human population. This ideology was used in Nazi Germany to justify their massacre of minority groups like Jews and the Romani.
Genome: The entire set of DNA in a cell
Centrifuged: A process that uses centrifugal forces to separate substances of different densities

References:
1.Funanage, Vicky L. “Impact of Genetic Testing on Human Health:: The Current Landscape and Future for Personalized Medicine.” Delaware journal of public health vol. 7,5 10-11. 15 Dec. 2021, doi:10.32481/djph.2021.12.005 Available from: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC9124557/#r1
- doi: 10.1126/science.zrxw8mv https://www.science.org/content/article/geneticsgroup-slams-company-using-its-data-screenembryos-genomes
- Carango, P et al. “Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy.”Genomics vol. 18,2 (1993): 340-8. doi:10.1006/geno.1993.1474 Available from: https://pubmed.ncbi.nlm.nih.gov/8288237/
4.First clinical validation of whole genome screening on standard trophectoderm biopsies of preimplantation embryos Yuntao Xia, Willy Chertman,DhruvaChandramohan , Maria Katz, Elan Bechor, Ben Podgursky,Michael H oxie, Qinnan Zhang, Jessica Kang, Edwina Blue, Justi nChen, Justin Schleede, Nathan Slotnick, Xiaoli Du, Jonathan Kort,Robert Boostanfar, Eric Urcia, Barry B ehr, Noor Siddiqui bioRxiv 2022.04.14.488421; doi: https://doi.org/10.1 101/2022.04.14.488421
Add comment
Comments